Agilent, CambTEK Ink Sample Prep Tech Co-marketing Pact | GenomeWeb

NEW YORK (GenomeWeb News) – Agilent Technologies will co-market CambTEK's extraction and sample prep technologies with its own liquid phase separation, life science, and chemical analysis instruments and software, the companies said today.

Under the agreement, the partners will co-market CambTEK's Rapid Extraction System (RES) for automated sample preparation alongside the Agilent instruments and software.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: new chromatin imaging approach, and more.

University of Wisconsin researchers uncover a mutation linked to Mauriac syndrome, which affects some children with type 1 diabetes.

Theranos has hired executives to oversee compliance and regulatory issues, the Wall Street Journal reports.

Chinese researchers to embark on a trial using a CRISPR/Cas9-based immunotherapy next month, Nature News reports.